Talc pleurodesis in recurrent malignant effusion - A prospective observation trial;DIE TALKUM-PLEURODESE BEI REZIDIVIERENDEM MALIGNEN PLEURAERGUSS - EINE PROSPEKTIVE BEOBACHTUNGSSTUDIE

Zentralblatt fur Chirurgie

Volumn 121, Issue 3, 1996, Pages 216-222

  Walter, M ^a   Turler A ^a   Schmitz Rixen, T ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

pleural effusion; pleurodesis; talc

Indexed keywords

BLEOMYCIN; DOXYCYCLINE; FIBRIN; LIDOCAINE; MINOCYCLINE; TALC; TETRACYCLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; PLEURA CANCER; PLEURA EFFUSION; PLEURODESIS; REGIONAL PERFUSION; SURGICAL TECHNIQUE; THORAX DRAINAGE;

ADULT; AGED; AGED, 80 AND OVER; CHEST TUBES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL RATE; TALC;

EID: 0029984395     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Aelony Y, King R, Boutin C: Thoracoscopic talc poudrage pleurodesis for chronic recurrent pleural effusions, Ann Intern Med 10 (1991) 778-782.
2. Alberts DS, Chen HS G, Mayersohn M: Bleomycin pharmakokonetics in man. II. Intracavitary administration, Cancer Chemoth Pharm 2 (1979) 127-132.
3. Ariel I, Oropeza R: Intracavitary administration of radioisotopes in the control of effusions due to cancer - results in in 267 patients, Cancer 19 (1967) 1096-1102.
4. Boniface E, Guerin JC: Interet du talcage par thoracoscopie dans les traitements symptomatique des pleuresies recidivantes. A propos de 302 cas, Rev Mal Resp 6 (1989) 133-139.
5. Boutin C: Pleurodesis for chronic pleural effusion. In: Boutin C; Viallat J R; Aelony Y (Eds.): Practical thoracoscopy. Berlin - Heidelbera - New York: Springer Verlag 1990.
6. Boutin C, Viallat J, Aelony Y, Currie JL, Weed JC, Creasman WT: Intracavitary Corynebacterium parvum for treatment of malignant effusions. Gynecol Oncol 16 (1983) 6-14.
7. Chambers J: Palliative treatment of neoplastic pleural effusion with intercostal intubation and talc instillation. West J Surg 66 (1958) 26-28.
8. Cust R, Fabel H: Fibrinkleber-Pleurodese bei rezidivierenden malignen Pleuraergüssen, Pneumonologie 43 (1989) 85-87.
9. Engel J: Tetracyclin- und NaOH-Pleurodese in der Palliativbehandlung maligner Pleuraergusse, Prax Pneumol 35 (1981) 1124-1126.
10. Felletti R, Ravazzoni C: Intrapleural Corynebacterium parvum for malignant pleural effusion. Thorax 38 (1983) 22-24.
11. Foresti V. Villa A: Corynebacterium parvum pleurodesis, Chest 107 (1995) 291-293.
12. Furrer M, Inderbitzi R: Pleurodeseverfahren bei malisnem Pleuraersuß. Schweiz Med Wschr 122 (1992) 181-188.
13. Guerin JC, Boniface E: Les methodes de pleurodese. Rev Prat 40 (1990) 1854-1856.
14. Gupta N, Opfell RW, Padova J, Margileth D, Souadjian J: Intrapleural bleomycin vs. tetracycline for control of malignant pleural effusion. A randomized study. Proc Am Assoc Cancer Res and Proc Am Soc Clin Oncol 21 (1980) 366.
15. Gust R, Fabel H: Fibrinkleber-Pleurodese bei rezidivierenden malignen Pleuraersüssen, Pneumonologie 43 (1989) 85-87.
16. Hamed H, Fentiman IS, Chaudary MA, Rubens RD: Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinomas of the breast. Br J Surg 76 (1989) 1266-1267.
17. Hartman DL, Gaither JM, Kesler KA, Mylet DM, Brown JW, Mathur PN: Comparison of insufflated talc under thoracoscopic guiadance with standard tetracyclin and bleomycin pleurodesis for control of malignant pleural effusions, J Thorac Cardiovasc Surg 4 (1993) 743-748.
18. Hatta T, Tsubuota N, Yoshimura M, Yanagawa M: Effect of intrapleural administration of minocycline on postoperative air leakage and malignant pleural effusion, Kyobu Geka 43 (1990) 283-286.
19. Hausheer FH, Yarbro W: Diagnosis and treatment of malignant pleural effusion. Semin Oncol 12 (1985) 54-75.
20. Hillerdal G, Kiviloog J, Nou E, Steinholtz L: Corynebacterium parvum in malignant pleural effusion. A randomized prospective study, Eur J Resp Dis 69 (1986) 204-206.
21. Inderbitzi R, Furrer M, Striffeler H: Die operative Thorakoskopie - Indikation und Technik. Frühergebnisse bei Spontanpneumothorax, Chirurg 63 (1992) 334-341.
22. Johnson C, Curzon P: Comparison of intrapleural bleomycin and tetracyclin in the treatment of malignant pleural effusions. Proc Brt Thor Soc 6 (1984).
23. Kessinger A, Wigton RS: Intracavitary bleomycin and tertracycline in the management of malignant pleural effusions. A randomized study, J Surg Oncol 36 (1987) 81-83.
24. Kreuser ED: Maligne Pleuraergüsse - Pathophysiologie, Diagnostik und Therapie. Dtsch Med Wschr 110 (1985) 1381-1386.
25. Kreuser ED, Seifried E, Harsch U, Brass B, Schreml W, Heimpel H: Fibrinpleurodese bei malignen Pleuraergüssen. Dtsch Med Wschr 110 (1985) 1365.
26. Lange P, Mortensen J, Groth S: Lung-function 22-35 years after treatment of idiopathic spontaneous pneumothorax with talc poudrage on simple drainage, Thorax 43 (1988) 559-561.
27. Leahy BC, Honeybourne D, Brear SG, Carroli KB, Thatcher N, Stretton TB: Treatment of malignant pleural effusion with intrapleural Corynebacterium parvum or tertracycline, Eur J Resp Dis 66 (1985) 50-54.
28. Mansson T: Treatment of malignant pleural effusion with doxycicline, Scand J Infect Dis 53 (1988) 29-34.
29. Martin N, Bains M, Beatte E: Indications for pleurectomy in malignant effusion. Cancer 35 (1975) 734-738.
30. Masuno T, Kishimoto S, Ogura T: The efficacy of LC 9018 in patients with malignant pleural effusion of primary lung cancer. Biotherapy 3 (1989) 1598-1606.
31. McLeod DT, Calveley PM A, Millar JW, Home NW: Further experience of Corynebacterium parvum in malignant pleural effusion. Thorax 40 (1985) 515-518.
32. Muir JF, Defouilloy C, Ndarurinze S, Hermant A, Quequet PM, Broussier PM, Aubry P, Desablens B: Utilisation de la doxycycline intrapleurale par lavagedrainage dans les épachements récidivants d'origine néoplastique, Rev Mal Respir 4 (1987) 29-33.
33. Ostrowski MJ: An assessment of the long-term results of controlling the reaccumulation of malignant effusion using intracavity bleomycin, Cancer 57 (1986) 721-727.
34. Ostrowski MJ, Halsall GM: Intracavitary bleomycin in the management of malignant effusions: A multicenter study. Cancer Treat Rep 66 (1982) 1903-1907.
35. Ostrowski MJ, Priestmann TH, Houston RF, Martin WM C: A randomized trial of intracavitary bleomycin and Corynebacterium parvum in the control of malignant pleural effusions, Radiother Oncol 14 (1989) 19-26.
36. Rinaldo JE, Owens GR, Robers RM: Adult respiratory distress syndrome following intrapleural instillation of talc, J Thorac Cardiovasc Surg 85 (1983) 523-526.
37. Rosso R, Rimoldi R, Salvati F, De Palma M, Cinqugrana A, Nicolo G, Ardizzoni A, Fusco U, Capacio A, Centofani R, Neri M, Cruciani R, Maistro L: Intrapleural natural Beta-Interferon in the treatment of malignant pleural effusions, Oncology 45 (1988) 253-256.
38. Ruckdeschel J, Moores D, Lee J: Management of malignant pleural effusions (MPE): a randomized comparison of tetracycline (TETRA) and bleomycin (BLEO), Proc Am Soc Clin Oncol 9 (1990) 323.
39. Sherman S, Grady KJ, Seidmann JC: Clinical experience with tetracycline-pleurodesis of malignant pleural effusions. South Med J 80 (1987) 716-719.
40. Sorensen P, Svendsen T, Enk B: Treatment of malignant pleural effusion with darinage with or without instillation of talc, Eur J Resp Dis 65 (1984) 131-135.
41. Taguchi T: Phase II clinical study of LC 9018 for various malignant tumors, Biotherapy 2 (1988) 532-543.
42. Walker-Renard PB, Vaughan LM, Sahn SA: Chemical pleurodesis for malignant pleural effusion, Ann Intern Med 120 (1994) 56-64.
43. Webb HE, Oaten SW, Pike CP: Treatment of malignant ascites and pleural effusions with Corynebacterium parvum, Brit Med J 1 (1978) 338-340.
44. Webb WR, Ozmen V, Moulder PV, Shabahang B, Breaux J: Iodized talc pleurodesis for the treatment of pleural effusions, J Thorac Cardiovasc Surg 103 (1992) 881-886.
45. Weissberg D, Ben-Zeef I: Talc pleurodesis, J Thorac Cardiovasc Surg 4 (1993) 689-695.